| The management of dermal filler complications. | |
| | |
MedLine Citation:
|
PMID: 19415581 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Injectable fillers have gained widespread acceptance among the public and provide a nonsurgical means of rejuvenating the face. As the demand for fillers increases, facial plastic surgeons must become not only expert injectors but also experts in managing the complications of fillers. Little scientific data exists regarding the incidence of complications, and more adverse effects may be seen with longer-term follow-up of patients. The purpose of this article is to review the most commonly encountered complications and management thereof. |
| | |
Authors:
|
Catherine P Winslow |
Publication Detail:
|
Type: Journal Article Date: 2009-05-04 |
Journal Detail:
|
Title: Facial plastic surgery : FPS Volume: 25 ISSN: 1098-8793 ISO Abbreviation: Facial Plast Surg Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-05-05 Completed Date: 2009-07-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8405303 Medline TA: Facial Plast Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 124-8 Citation Subset: D |
Affiliation:
|
Indiana University School of Medicine, Indianapolis, Indiana, USA. drwinslow@indyface.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biocompatible Materials
/
administration & dosage*,
adverse effects* Cicatrix / etiology, therapy Contusions / etiology, therapy Cosmetic Techniques / adverse effects* Edema / etiology, therapy Erythema / etiology, therapy Face Facial Pain / etiology, therapy Granuloma, Foreign-Body / etiology, therapy Histamine Antagonists / therapeutic use Humans Hypersensitivity / drug therapy, etiology Ice Inflammation / etiology, therapy Injections, Intradermal / adverse effects* Necrosis / drug therapy, etiology Pigmentation Disorders / etiology, therapy Rejuvenation Skin Aging Vasodilator Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Biocompatible Materials; 0/Histamine Antagonists; 0/Ice; 0/Vasodilator Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New Fillers under Consideration: What Is the Future of Injectable Aesthetics?
Next Document: The canadian experience with fillers.